Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,289 public trials 284 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Completed

Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer

NCT02459652

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
View all 22 locations
View Trial Details
Completed

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer

NCT02923921

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Cancer Treatment Centers of America Goodyear, Arizona, United States
  • University of Arizona Cancer Center Phoenix, Arizona, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
View all 130 locations
View Trial Details
Completed

Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma

NCT02289898

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Providence Saint Joseph Medical Center Burbank, California, United States
  • City of Hope Duarte, California, United States
  • Scripps Cancer Center La Jolla, California, United States
View all 42 locations
View Trial Details
Completed

Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer

NCT02050178

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Hospital Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions